Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Renin | ||
Ligand | BDBM50434421 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_962066 (CHEMBL2388034) | ||
IC50 | 1.3±n/a nM | ||
Citation | Nakamura, Y; Fujimoto, T; Ogawa, Y; Namiki, H; Suzuki, S; Asano, M; Sugita, C; Mochizuki, A; Miyazaki, S; Tamaki, K; Nagai, Y; Inoue, S; Nagayama, T; Kato, M; Chiba, K; Takasuna, K; Nishi, T Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: discovery of DS-8108b, an orally active renin inhibitor. Bioorg Med Chem21:3175-96 (2013) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Renin | |||
Name: | Renin | ||
Synonyms: | Angiotensinogenase | REN | RENI_HUMAN | ||
Type: | Enzyme | ||
Mol. Mass.: | 45058.99 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 406 | ||
Sequence: |
| ||
BDBM50434421 | |||
n/a | |||
Name | BDBM50434421 | ||
Synonyms: | CHEMBL2387571 | ||
Type | Small organic molecule | ||
Emp. Form. | C31H46ClN5O4 | ||
Mol. Mass. | 588.181 | ||
SMILES | CC[C@H](C[C@H](O)[C@@H](N)CN1CC(=O)N(CC1(C)C)c1ccccc1Cl)C(=O)NC1C2CC3CC1CC(C3)(C2)C(N)=O |r,wU:4.4,2.2,wD:6.6,TLB:27:28:34.37.35:30.31.32,27:28:32:34.35.36,37:35:28.29.30:32,38:35:28:30.31.32,THB:37:29:32:34.35.36,36:35:28:30.31.32,36:31:28:34.37.35,(14.47,-18.32,;13.13,-19.09,;13.13,-20.63,;11.8,-21.4,;10.46,-20.63,;10.47,-19.09,;9.13,-21.39,;7.8,-20.62,;9.13,-22.93,;7.79,-23.7,;6.46,-22.93,;5.12,-23.7,;3.78,-22.94,;5.13,-25.24,;6.46,-26.01,;7.79,-25.24,;9.27,-25.64,;8.19,-26.73,;3.79,-26.02,;2.45,-25.26,;1.13,-26.03,;1.12,-27.57,;2.46,-28.34,;3.79,-27.57,;5.13,-28.34,;14.47,-21.4,;14.46,-22.94,;15.8,-20.63,;17.13,-21.41,;18.63,-20.99,;18.63,-19.39,;19.67,-18.17,;18.32,-18.64,;18.33,-20.13,;19.66,-20.62,;21.05,-20.27,;21.07,-18.74,;20.04,-21.55,;22.38,-21.04,;23.71,-20.27,;22.38,-22.58,)| | ||
Structure |